[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342391-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342391-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pp2a-inhibition-causes-synthetic-lethality-in-brca2-mutated-prostate-cancer-models-via-spindle-assembly-checkpoint-reactivation","PP2A inhibition causes synthetic lethality in BRCA2-mutated prostate cancer models via spindle assembly checkpoint reactivation","","Mutations in BRCA2 increase prostate cancer risk, yet BRCA2 loss paradoxically enables survival in some cancer cells. This study performs forward genetic synthetic viability screenings in Caenorhabditis elegans brc-2 mutants and identifies Ceubxn-2 inactivation as a viability rescue. In mammals, NSFL1C loss suppresses spindle assembly checkpoint activation, promotes BRCA2-deficient cell survival, and mechanistically recruits USP9X to inhibit AURKB polyubiquitination while limiting AURKB removal from centromeres, enabling reactivation for synthetic lethality using PP2A inhibitors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pp2a-inhibition-causes-synthetic-lethality-in-brca2-mutated-prostate-cancer-models-via-spindle-assembly-checkpoint-reactivation/342391/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pp2a-inhibition-causes-synthetic-lethality-in-brca2-mutated-prostate-cancer-models-via-spindle-assembly-checkpoint-reactivation/342391.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does this study identify in BRCA2-deficient models?","Question",{"text":63,"@type":64},"It finds that Ceubxn-2 inactivation rescues viability in C. elegans brc-2 mutants, and that NSFL1C loss suppresses spindle assembly checkpoint activation while promoting survival of BRCA2-deficient cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is the spindle assembly checkpoint mechanistically regulated?",{"text":68,"@type":64},"The study reports that NSFL1C recruits USP9X to inhibit polyubiquitination of AURKB and reduce AURKB removal from centromeres by VCP, which is essential for SAC activation.",{"name":70,"@type":61,"acceptedAnswer":71},"How do PP2A inhibitors relate to synthetic lethality?",{"text":72,"@type":64},"SAC inactivation is common in BRCA2-deficient prostate cancer patients; PP2A inhibitors can reactivate the SAC and induce synthetic lethality in BRCA2-deficient tumor models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342391,1790953936,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","The Journal of Clinical Investigation RESEAR CH ARTICLE  \nPP2A inhibition causes synthetic lethalityin BRCA2-mutated prostate cancer models via spindle assembly checkpoint reactivation  \nJian Wang,1 Yuke Chen,2 Shiwei Li,1 Wanchang Liu,1 Xiao Albert Zhou,1 Yefei Luo,1 Zhanzhan Xu,1 Yundong Xiong,1 Kaiqi Cheng,1 Mingjian Ruan,2 Wei Yu,2 Xiaoman Li,1 Weibin Wang,1 and Jiadong Wang1  \n1Department of Radiation Medicine, School of Basic Medical Sciences, Peking University International Cancer Institute, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China. 2Department of Urology, Peking University First Hospital, Beijing, China.  \nMutations in the BRCA2 tumor suppressor gene have been associated with an increased risk of developing prostate cancer. One of the paradoxes concerning BRCA2 is the fact that its inactivation affects genetic stability and is deleterious for cellular and organismal survival, while BRCA2-mutated cancer cells adapt to this detriment and malignantly proliferate. Therapeutic strategies for tumors arising from BRCA2 mutations may be discovered by understanding these adaptive mechanisms. In this study, we conducted forward genetic synthetic viability screenings in Caenorhabditis elegans brc-2 (Cebrc-2) mutants and found that Ceubxn-2 inactivation rescued the viability of Cebrc-2 mutants. Moreover, loss of NSFL1C, the mammalian orthologof CeUBXN-2, suppressed the spindle assembly checkpoint (SAC) activation and promoted the survival of BRCA2-deficient cells. Mechanistically, NSFL1C recruited USP9X to inhibit the polyubiquitination of AURKB and reduce the removal of AURKB from the centromeres by VCP, which is essential for SAC activation. SAC inactivation is common in BRCA2-deficient prostate cancer patients, but PP2A inhibitors could reactivate the SAC and achieve BRCA2-deficient prostate tumor synthetic lethality. Our research reveals the survival adaptation mechanism of BRCA2-deficient prostate tumor cells and provides different angles for exploring synthetic lethal inhibitors in addition to targeting DNA damage repair pathways.  \nIntroduction  \nGermline mutations of BRCA2 predispose humans to prostate, breast, ovarian, and pancreatic cancers (1, 2). As a tumor suppressor protein, BRCA2 is essential for stabilizing stalled replication forks (2, 3) and promoting the repair of replication-related DNA damage by homologous recombination (HR) (2), and for the role it plays in chromosome segregation during mitosis (1, 4, 5) . As a result, BRCA2-deficient tumor cells need to partially restore these functions or possess alternative repair pathways to survive, owing to highly unstable genomes and chromosomes.  \nThe role of BRCA2 in cancer susceptibility is poorly understood. Mice homozygous for Brca2 exon 10 and 11 truncating mutations exhibit embryonic lethality (6–8), whereas a minority of homozygous mice harboring a Brca2 truncation at the 3′ end of exon 11 survive to adulthood and develop thymic lymphomas (9, 10). One of the paradoxes concerning BRCA2 is that it is not only necessary during biological development, where its absence leads to embryonic lethality, but also is essential for cell viability (6–11). How these BRCA2-deficient tumor cells survive despite accumu-  \nAuthorship note: Jian Wang, Yuke Chen, and Shiwei Li contributed equally to this work. Conflict of interest: The authors have declared that no conflict of interest exists. Copyright: © 2024, Wang et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nSubmitted: May 8, 2023; Accepted: October 31, 2023; Published: January 2, 2024.  \nReference information: J Clin Invest. 2024;134(1):e172137.  \n[https://doi.org/10.1172/JCI172137](https://doi.org/10.1172/JCI172137).  \nlating DNA damage and abnormal mitosis is not fully understood, and this lethality must be overcome during tumorigenesis. In fact, concomitant deletion ofp53 in mic","cbCaijXSwWSopAQl","https://ap.wps.com/l/cbCaijXSwWSopAQl","pdf",15569189,18,"English","# Introduction\n## BRCA2 loss and survival paradox\n## Synthetic lethality targets and adaptive mechanisms","[{\"question\":\"What does this study identify in BRCA2-deficient models?\",\"answer\":\"It finds that Ceubxn-2 inactivation rescues viability in C. elegans brc-2 mutants, and that NSFL1C loss suppresses spindle assembly checkpoint activation while promoting survival of BRCA2-deficient cells.\"},{\"question\":\"How is the spindle assembly checkpoint mechanistically regulated?\",\"answer\":\"The study reports that NSFL1C recruits USP9X to inhibit polyubiquitination of AURKB and reduce AURKB removal from centromeres by VCP, which is essential for SAC activation.\"},{\"question\":\"How do PP2A inhibitors relate to synthetic lethality?\",\"answer\":\"SAC inactivation is common in BRCA2-deficient prostate cancer patients; PP2A inhibitors can reactivate the SAC and induce synthetic lethality in BRCA2-deficient tumor models.\"}]","PP2A inhibition causes synthetic lethality in BRCA2-mutated prostate cancer models via spindle assembly checkpoint reactivation | PDF",1790046401,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75557aae539868ceb91235344bcc48f8.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/446f4e11c86a1c28a0ae903f2977f7d0.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56fa57538bf2403d2f753aa580e62eeb.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/238c0e30b3a40c0b082e461f89f8dd17.webp",980,1311]